Spots Global Cancer Trial Database for uterine fibroids
Every month we try and update this database with for uterine fibroids cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Multi-Center, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids | NCT02301897 | Uterine Fibroid... | Telapristone Ac... Placebo | 18 Years - 47 Years | Repros Therapeutics Inc. | |
| Association Between Vitamin D and the Risk of Uterine Fibroids | NCT03586947 | Gynaecological ... Vitamin D Defic... Uterine Fibroid... | Vitamin D3 400 ... | 35 Years - 50 Years | Second Affiliated Hospital of Wenzhou Medical University | |
| Safety of Treatment of Uterine Fibroids With Asoprisnil | NCT00156208 | Fibroid Uterus Leiomyoma Menorrhagia Metrorrhagia Uterine Fibroid... | Asoprisnil Asoprisnil | 18 Years - | Abbott | |
| Efficacy and Safety of Rapamycin (Sirolimus) in the Treatment of Symptomatic Uterine Fibroids and Leiomyomatosis | NCT03500367 | Uterine Fibroid... | rapamycin | 18 Years - 50 Years | Peking Union Medical College Hospital | |
| Clinical Test of the MRgHIFU System on Uterine Fibroids | NCT02283502 | Uterine Fibroid... | MRgHIFU system | 35 Years - 45 Years | Chang Gung Memorial Hospital | |
| ExAblate Treatment of Uterine Fibroids for Fertility Enhancement | NCT00730886 | Uterine Fibroid... | ExAblate 2000 Myomectomy | 21 Years - 40 Years | InSightec | |
| Comparing Patient-Centered Outcomes After Treatment for Uterine Fibroids | NCT02819609 | Uterine Fibroid... | myomectomy endometrial abl... uterine artery ... MRI-guided focu... | 18 Years - 54 Years | Quintiles, Inc. | |
| Ulipristal Acetate 10 mg and Asisted Reproduction | NCT02425878 | Intramural Fibr... Uterine Fibroid... | Ulipristal Acet... Placebo | 18 Years - 50 Years | Instituto Valenciano de Infertilidad, IVI VALENCIA | |
| The Effects of Uterine Fibroids on Pregnancy in Women | NCT06020924 | Female Infertil... Uterine Fibroid | No intervention | 20 Years - 50 Years | Tongji Hospital | |
| Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914 | NCT00290251 | Leiomyoma | ulipristal acet... ulipristal acet... placebo | 25 Years - 50 Years | National Institutes of Health Clinical Center (CC) | |
| A Study to Evaluate Awareness and Knowledge of the Fibristal Additional Risk Minimization Measures Among Healthcare Professionals in Canada | NCT04567589 | Uterine Fibroid... | - | Allergan | ||
| An Extension Study Evaluating Safety and Efficacy of Proellex® In Women Who Have Previously Completed ZPU 003 Ext | NCT00958893 | Uterine Fibroid... | 25 mg Proellex | 18 Years - 50 Years | Repros Therapeutics Inc. | |
| Safety and Efficacy of Telapristone Acetate (Proellex®) Administered Vaginally for the Treatment of Uterine Fibroids | NCT02323646 | Uterine Fibroid... | Placebo Telapristone Ac... | 18 Years - 47 Years | Repros Therapeutics Inc. | |
| Post-Operative Pain Management in Patients Undergoing Uterine Artery Embolisation for Symptomatic Leiomyomata | NCT00163930 | Uterine Fibroid... | 18 Years - 80 Years | Bayside Health | ||
| Risk Factors for Uterine Fibroids: A Case Control Study | NCT00339547 | Uterine Fibroid... | 35 Years - 50 Years | National Institutes of Health Clinical Center (CC) | ||
| A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids | NCT00160459 | Leiomyoma | Asoprisnil Asoprisnil Asoprisnil Placebo | 18 Years - 48 Years | Abbott | |
| Safety of Treatment of Uterine Fibroids With Asoprisnil | NCT00156208 | Fibroid Uterus Leiomyoma Menorrhagia Metrorrhagia Uterine Fibroid... | Asoprisnil Asoprisnil | 18 Years - | Abbott | |
| Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids | NCT00683917 | Uterine Fibroid... | Proellex 25 mg Proellex 50 mg Lupron Depot | 18 Years - 45 Years | Repros Therapeutics Inc. | |
| A Study to Evaluate Awareness and Knowledge of the Fibristal Additional Risk Minimization Measures Among Healthcare Professionals in Canada | NCT04567589 | Uterine Fibroid... | - | Allergan | ||
| A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids | NCT00152256 | Fibroid Uterus Leiomyoma Menorrhagia Metrorrhagia Uterine Fibroid... | Asoprisnil Asoprisnil Placebo | 18 Years - 53 Years | Abbott | |
| Optimal Order of Concurrent Office Hysteroscopy and Endometrial Biopsy | NCT02472184 | Uterine Fibroid... Vaginal Bleedin... | Office hysteros... Endometrial bio... | 18 Years - 70 Years | University of South Florida | |
| Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy | NCT04756037 | Contraception | Relugolix Combi... | 18 Years - 50 Years | Sumitomo Pharma Switzerland GmbH | |
| Uterine Artery Occlusion for Fibroid Related Bleeding | NCT00496067 | Menorrhagia Uterine Fibroid... | Doppler-Guided ... | 25 Years - 50 Years | Ethicon, Inc. | |
| Observational Prospective Study on Patients With Symptomatic Uterine Fibroids Treated With VizAblate® Intrauterine-ultrasound Guided RF Ablation | NCT01998854 | Menorrhagia Leiomyoma Uterine Fibroid... Uterine Fibroma Uterine Neoplas... | VizAblate Syste... | 28 Years - | Gynesonics | |
| Uterine Leiomyoma Treatment With Radiofrequency Ablation | NCT01840124 | Uterine Fibroid... | Radiofrequency ... | 21 Years - | University of California, San Francisco | |
| Laparoscopic Radiofrequency Ablation (RFA) of Symptomatic Uterine Fibroids | NCT00874029 | Uterine Fibroid... Uterine Myomas | Halt Procedure | 25 Years - | Acessa Health, Inc. | |
| MyoSure Hysteroscopic Tissue Removal System Registry Study | NCT01369758 | Uterine Fibroid... Polyps | MyoSure Tissue ... | 18 Years - 65 Years | Hologic, Inc. | |
| Extension of Study ZPV-200 | NCT01631903 | Uterine Fibroid... | telepristone ac... telepristone ac... telepristone ac... telepristone ac... telepristone ac... | 18 Years - 47 Years | Repros Therapeutics Inc. | |
| Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids | NCT03194646 | Uterine Fibroid... | Vilaprisan (BAY... Vilaprisan (BAY... Vilaprisan (BAY... Standard of car... Vilaprisan (BAY... Vilaprisan (BAY... Vilaprisan (BAY... | 18 Years - | Bayer | |
| Laparoscopic Radiofrequency Ablation (RFA) of Symptomatic Uterine Fibroids | NCT00874029 | Uterine Fibroid... Uterine Myomas | Halt Procedure | 25 Years - | Acessa Health, Inc. | |
| Clinical Study of the Mirabilis High-Intensity Focused Ultrasound System for Non-Invasive Treatment of Uterine Fibroids | NCT01946178 | Uterine Fibroid... | Mirabilis High-... | 18 Years - 55 Years | Mirabilis Medica, Inc. | |
| Fibroid Ablation Study | NCT01226290 | Leiomyoma Uterine Fibroid... Menorrhagia | VizAblate Syste... | 28 Years - | Gynesonics | |
| Uterine Fibroid Pregnancy Registry | NCT00232713 | Birth Defects Pregnancy Uterine Fibroid... | 20 Years - 55 Years | Syneos Health | ||
| Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids | NCT00737282 | Uterine Fibroid... | Proellex 25 mg Proellex 50 mg | 18 Years - 48 Years | Repros Therapeutics Inc. | |
| PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (PEARLIII-extension Study) | NCT01252069 | Uterine Fibroid... | PGL4001, placeb... PGL4001, proges... | 18 Years - 48 Years | PregLem SA | |
| Uterine Artery Occlusion for Fibroid Related Bleeding | NCT00496067 | Menorrhagia Uterine Fibroid... | Doppler-Guided ... | 25 Years - 50 Years | Ethicon, Inc. | |
| Efficacy Study of Magnetic Resonance (MR) Guided Focused Ultrasound in the Treatment of Large Fibroids | NCT00159328 | Uterine Fibroid... | Magnetic Resona... | 18 Years - | Imperial College London | |
| Evaluating the Safety and Efficacy of Proellex® in Premenopausal Women With Symptomatic Uterine Fibroids | NCT00853567 | Uterine Fibroid... | Proellex placebo | 18 Years - 48 Years | Repros Therapeutics Inc. | |
| Clinical Study of the Mirabilis High-Intensity Focused Ultrasound System for Non-Invasive Treatment of Uterine Fibroids | NCT01946178 | Uterine Fibroid... | Mirabilis High-... | 18 Years - 55 Years | Mirabilis Medica, Inc. | |
| Post-Operative Pain Management in Patients Undergoing Uterine Artery Embolisation for Symptomatic Leiomyomata | NCT00163930 | Uterine Fibroid... | 18 Years - 80 Years | Bayside Health | ||
| Minimally Invasive Benign Hysterectomy | NCT01865929 | Menorrhagia Metrorrhagia Uterine Fibroid... Cervical Dyspla... | Robotic hystere... Vaginal or lapa... | 25 Years - | Region Skane | |
| Phase III Study of MR-Guided Focused Ultrasound Surgery for the Treatment of Uterine Fibroids Compared to Myomectomy | NCT03948789 | Uterine Fibroid... | Magnetic Resona... Myomectomy (lap... | 18 Years - | Krankenhaus Nordwest | |
| Minimally Invasive Benign Hysterectomy | NCT01865929 | Menorrhagia Metrorrhagia Uterine Fibroid... Cervical Dyspla... | Robotic hystere... Vaginal or lapa... | 25 Years - | Region Skane | |
| Comparison Between Laparoendoscopic Single-site Surgery and Multi-port Laparoscopy in Treating Uterine Fibroids | NCT06244251 | Uterine Fibroid Uterine Sarcoma Uterine Leiomyo... | TU-LESS MPLS | - | West China Second University Hospital | |
| A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE) | NCT00628901 | Leiomyoma Uterine Fibroid... Uterine Neoplas... Menorrhagia Leiomyomatosis | Uterine Fibroid... Contour SE™ Mic... Embosphere® Mic... | 18 Years - | Boston Scientific Corporation | |
| Pharmacokinetics and Safety of Vilaprisan in Renal Impairment | NCT03411980 | Uterine Fibroid... Endometriosis | Vilaprisan (BAY... | 18 Years - 79 Years | Bayer | |
| Embozene Microspheres for Uterine Fibroid Embolization (UFE) | NCT01675011 | Uterine Fibroid... | Embozene® Micro... Embosphere® | 30 Years - 50 Years | Boston Scientific Corporation | |
| The Effect of Mifepristone on Uterine Fibroids and Breast Tissue | NCT00579475 | Uterine Fibroid... | Mifegyne placebo | 18 Years - | Karolinska Institutet | |
| Evaluation of Uterine Patency Following Sonography-guided Transcervical Ablation of Fibroids | NCT02844920 | Uterine Fibroid... Adhesions | Intrauterine ul... | 18 Years - | Gynesonics | |
| PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata | NCT01642472 | Uterine Fibroid... | Ulipristal Acet... | 18 Years - | PregLem SA | |
| Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry | NCT02100904 | Uterine Fibroid... | Radiofrequency ... Myomectomy of f... | 21 Years - | University of California, San Francisco | |
| PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (PEARLIII-extension Study) | NCT01252069 | Uterine Fibroid... | PGL4001, placeb... PGL4001, proges... | 18 Years - 48 Years | PregLem SA | |
| Ovarian Reserve Modification After Lps Hysterectomy With Bilateral Salpingectomy | NCT02086344 | Uterine Fibroid... Adenomyosis Pelvic Pain Pelvic Prolapse | PBS TLH _adnexal pr... | 35 Years - 50 Years | University Magna Graecia | |
| Uterine Artery Embolization(UAE) Versus High-Intensity-Focused-Ultrasound(HIFU) for Treatment of Uterine Fibroids | NCT01834703 | Uterine Fibroid... | UAE HIFU | 30 Years - 47 Years | Chinese University of Hong Kong | |
| AMH Levels Change During Treatment With GnRh Agonist | NCT02086279 | Uterine Fibroid... Endometriosis Endometriosis o... Pelvic Pain | GnRH analogue | 18 Years - 45 Years | University Magna Graecia | |
| ExAblate UF V2 System for the Treatment of Symptomatic Uterine Fibroids | NCT01285960 | Uterine Fibroid... | ExAblate Treatm... | 18 Years - 64 Years | InSightec | |
| Does 3D Laparoscopy Improve Vaginal Cuff Suture Time? | NCT02192606 | Uterine Fibroid... Abnormal Uterin... Pelvic Pain Adenomyosis | Storz 3D Laparo... 2D Laparoscopy | 18 Years - 80 Years | Brigham and Women's Hospital | |
| AMH Levels Change During Treatment With GnRh Agonist | NCT02086279 | Uterine Fibroid... Endometriosis Endometriosis o... Pelvic Pain | GnRH analogue | 18 Years - 45 Years | University Magna Graecia | |
| Studies on the H Pipelle, a New Device for Endometrial Sampling at Hysteroscopy | NCT00755651 | Abnormal Uterin... | Endometrial bio... | 20 Years - 80 Years | Royal Free Hampstead NHS Trust | |
| Pilot Study of MRI-Guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids | NCT00837161 | Uterine Fibroid... Uterine Leiomyo... | Philips MR guid... | 18 Years - 59 Years | Philips Healthcare | |
| FRIEND: Fibroids and Unexplained Infertility Treatment With Epigallocatechin Gallate; A Natural CompounD in Green Tea | NCT05364008 | Leiomyoma, Uter... | Green Tea Extra... Placebo | 18 Years - 40 Years | Yale University | |
| Mifepristone to Treat Uterine Fibroids | NCT01786226 | Uterine Fibroid... | Oral administra... Oral administra... | 18 Years - 50 Years | Mediterranea Medica S. L. | |
| Fibroid Ablation Study | NCT01226290 | Leiomyoma Uterine Fibroid... Menorrhagia | VizAblate Syste... | 28 Years - | Gynesonics | |
| PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata | NCT01642472 | Uterine Fibroid... | Ulipristal Acet... | 18 Years - | PregLem SA | |
| Magnetic Resonance Guided Focused Ultrasound for Uterine Fibroids | NCT01377519 | Uterine Fibroid... | MR Guided Focus... Placebo MR Guid... | 18 Years - 99 Years | University of California, San Francisco | |
| Treatment of Benign Uterine Disorders Using High Intensity Focused Ultrasound (MR-HIFU) | NCT02914704 | Uterine Fibroid... Adenomyosis | MRI-HIFU | 18 Years - 50 Years | Turku University Hospital | |
| Biologic Predictors of Leiomyoma Treatment Outcomes | NCT01936493 | Uterine Leiomyo... Fibroids Uterine Fibroid... Myomas | DNA analysis Hormonal analys... | 18 Years - 99 Years | Mayo Clinic | |
| Does 3D Laparoscopy Improve Vaginal Cuff Suture Time? | NCT02192606 | Uterine Fibroid... Abnormal Uterin... Pelvic Pain Adenomyosis | Storz 3D Laparo... 2D Laparoscopy | 18 Years - 80 Years | Brigham and Women's Hospital | |
| The FIRSTT: Comparing MRgFUS(MR-guided Focused Ultrasound) Versus UAE (Uterine Artery Embolization)for Uterine Fibroids. | NCT00995878 | Symptomatic Ute... Fibroids Uterine Fibroid... Myomas | Focused ultraso... Uterine artery ... | 25 Years - | Mayo Clinic | |
| Phase III Study of MR-Guided Focused Ultrasound Surgery for the Treatment of Uterine Fibroids Compared to Myomectomy | NCT03948789 | Uterine Fibroid... | Magnetic Resona... Myomectomy (lap... | 18 Years - | Krankenhaus Nordwest | |
| Predictive Factors for Complete Myoma Resection During Hysteroscopic Myomectomy | NCT04400942 | Uterine Fibroid... Uterine Myomas | Transvaginal ul... Anamnesis Operative hyste... | 18 Years - | Ospedale Policlinico San Martino | |
| Efficacy and Safety of Rapamycin (Sirolimus) in the Treatment of Symptomatic Uterine Fibroids and Leiomyomatosis | NCT03500367 | Uterine Fibroid... | rapamycin | 18 Years - 50 Years | Peking Union Medical College Hospital | |
| Therapeutic MRI Guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids | NCT01141062 | Uterine Leiomyo... | Philips MR-guid... | 18 Years - 59 Years | Philips Healthcare | |
| An Extension Study of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids | NCT02811159 | Uterine Fibroid... | Telapristone ac... | 18 Years - 47 Years | Repros Therapeutics Inc. | |
| Implementation of Uterine Fibroid Option Grid Patient Decision Aids Across Five Organizational Settings | NCT03985449 | Uterine Fibroid | Uterine Fibroid... Uterine Fibroid... Uterine Fibroid... | 18 Years - | Dartmouth-Hitchcock Medical Center | |
| Magnetic Resonance (MR) Guided Focused Ultrasound Surgery of Uterine Fibroids | NCT00131365 | Leiomyoma | ExAblate 2000 | - | InSightec | |
| PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata | NCT01156857 | Uterine Fibroid... | PGL4001, placeb... PGL4001, proges... | 18 Years - 48 Years | PregLem SA | |
| Mode of Action Study of Vilaprisan and Ulipristal Acetate in Patients With Uterine Fibroids for Whom Surgery is Planned | NCT03342859 | Leiomyoma | Vilaprisan, BAY... Ulipristal | 18 Years - | Bayer | |
| Uterine Artery Embolization(UAE) Versus High-Intensity-Focused-Ultrasound(HIFU) for Treatment of Uterine Fibroids | NCT01834703 | Uterine Fibroid... | UAE HIFU | 30 Years - 47 Years | Chinese University of Hong Kong | |
| Efficacy and Safety of TAK-385 in the Treatment of Uterine Fibroids | NCT01452659 | Uterine Fibroid... | TAK-385 TAK-385 TAK-385 Placebo | 20 Years - | Takeda |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
